Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|March 19, 2024
Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell TherapiesHardik Mody, Dhruvitkumar S Sutaria, Dale Miles
Pharmaceutical Research|March 19, 2017
Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic LoadingDhruvitkumar S Sutaria, Mohamed Badawi, Mitch A Phelps, et al.
JCO Clinical Cancer Informatics|April 28, 2023
Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning-Based InvestigationRashed Harun, Rucha Sane, Kenta Yoshida, et al.
Pharmaceutics|October 27, 2022
Drug-Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate CancerDhruvitkumar S Sutaria, Grozdana Rasuo, Adam Harris, et al.
Journal of Clinical Pharmacology|August 17, 2021
Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic FunctionRucha Sane, Vikram Malhi, Dhruvitkumar S Sutaria, et al.
Pharmaceutics|July 13, 2019
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population PharmacokineticsJürgen B Bulitta, Yuanyuan Jiao, Cornelia B Landersdorfer, et al.
Clinical and Translational Science|October 5, 2022
Mitigating ipatasertib-induced glucose increase through dose and meal timing modificationsDhruvitkumar S Sutaria, Priya Agarwal, Kuan-Chieh Huang, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniaeDhruvitkumar S Sutaria, Bartolome Moya, Kari B Green, et al.
Clinical Pharmacology and Therapeutics|April 27, 2024
Evaluation of Patient-Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small MoleculesSandhya Mandlekar, Dhruvitkumar S Sutaria, Xiaoyun Yang, et al.
Functional & Integrative Genomics|August 20, 2016
miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethalAna Clara P Azevedo-Pouly, Dhruvitkumar S Sutaria, Jinmai Jiang, et al.
Pageof 3